Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | S-1/A | S-1 |
| Revenues |
| BELARUS | 8 | 7 | 8 | | |
| UKRAINE | 7 | 12 | 14 | | |
| Ophthalmic Pharmaceuticals | 677 | 704 | 726 | | |
| Surgical | 718 | 718 | 577 | | |
| U.S. and Puerto Rico | 1,695 | 1,618 | 1,558 | | |
| China | 343 | 390 | 280 | | |
| France | 195 | 201 | 174 | | |
| |
| EBIT |
| Ophthalmic Pharmaceuticals | 202 | 290 | 302 | | |
| Surgical | 42 | 75 | 18 | | |
| |
| Mix |
| BELARUS | 0.2% | 0.2% | 0.2% | | |
| UKRAINE | 0.2% | 0.3% | 0.4% | | |
| Ophthalmic Pharmaceuticals | 18.0% | 18.7% | 21.3% | | |
| Surgical | 19.1% | 19.1% | 16.9% | | |
| U.S. and Puerto Rico | 45.0% | 43.0% | 45.7% | | |
| China | 9.1% | 10.4% | 8.2% | | |
| France | 5.2% | 5.3% | 5.1% | | |
| |
| Growth |
| BELARUS | 14.3% | -12.5% | | | |
| UKRAINE | -41.7% | -14.3% | | | |
| Ophthalmic Pharmaceuticals | -3.8% | -3.0% | | | |
| Surgical | 0.0% | 24.4% | | | |
| U.S. and Puerto Rico | 4.8% | 3.9% | | | |
| China | -12.1% | 39.3% | | | |
| France | -3.0% | 15.5% | | | |
|